Morbidity of intraoperative OKT3 administration in primary cadaveric renal transplant recipients.
Kupin
W
W
Henry Ford Hospital, Detroit, Michigan 48202.
Venkat
K K
KK
Ikemiyashiro
D
D
Ocdol
H
H
Mozes
M
M
Anaise
D
D
Johnson
C
C
D000328:Adult; D001794:Blood Pressure; D002102:Cadaver; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007432:Intraoperative Period; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009017:Morbidity; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011674:Pulse
D016853:Muromonab-CD3